台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    98.8
  • 漲跌
    ▲1.5
  • 漲幅
    +1.54%
  • 成交量
    677
  • 產業
    上櫃 生技醫療類股
  • 309人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
智擎 (4162)籌碼相關-元大-彰化 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0402/1602/2603/1003/2004/0104/039095100105110115120125May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

元大-彰化 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/020.298.600.199.0998.800.11,7700.00%
2025/04/010.198.380.297.9897.3001,7730.00%
2025/03/31198.00296.7596.20-11,771-0.06%
2025/03/286101.171101.00100.5051,7520.29%
2025/03/261104.5000.00104.5011,7230.06%
2025/03/252105.7500.00104.5021,7190.12%
2025/03/2400.001106.50105.50-11,714-0.06%
2025/03/212105.500.1106.50106.501.91,7140.11%
2025/03/2000.004106.13106.00-41,713-0.23%
2025/03/191105.0000.00104.5011,7180.06%
2025/03/182106.5000.00106.5021,7130.12%
2025/03/172106.251107.00105.0011,7140.06%
2025/03/1400.002104.75105.00-21,713-0.12%
2025/03/131103.003104.00103.50-21,707-0.12%
2025/03/121107.5011107.00107.00-101,695-0.59%
2025/03/110105.501106.00107.00-11,697-0.06%
2025/03/072108.004109.75107.50-21,665-0.12%
2025/03/062114.503111.50111.00-11,647-0.06%
2025/03/053115.001115.46115.5021,6450.12%
2025/03/043113.172114.25114.5011,6340.06%
2025/03/032113.501114.00112.5011,6200.06%
2025/02/272113.5000.00109.0021,5680.13%
2025/02/2618117.2522118.23115.50-41,553-0.26%
2025/02/252113.001113.00113.0011,4430.07%
2025/02/211113.503112.67113.00-21,412-0.14%
2025/02/1900.001109.50110.00-11,396-0.07%
2025/02/183109.8300.00110.0031,4010.21%
2025/02/1700.001113.00112.50-11,397-0.07%
2025/02/140111.2500.00111.5001,4080.00%
2025/02/130110.5000.00111.5001,4130.00%
2025/02/120.5111.001111.00112.00-0.51,408-0.04%
2025/02/1115111.8000.00109.00151,3921.08%
2025/02/101.3118.2300.00118.501.31,3370.10%
2025/02/073.7118.144.5118.56120.50-0.81,351-0.06%
2025/02/0612118.429.2119.15119.002.81,3290.21%
2025/02/0500.004111.63113.00-41,194-0.33%
2025/01/160.194.7000.0095.100.11,3860.00%
2025/01/14095.8000.0096.1001,3720.00%
2025/01/09198.71195.0094.6001,3410.00%
2025/01/070.1101.5000.00101.500.11,2750.01%
2025/01/03197.201.298.2598.30-0.21,240-0.02%
2024/12/2700.00192.2092.00-11,223-0.08%
2024/12/2600.00191.9092.50-11,225-0.08%
2024/12/17187.1000.0086.7011,2230.08%
2024/12/161.187.22186.3086.300.11,2160.00%
2024/12/130.189.5000.0088.800.11,2090.00%
2024/12/10292.9000.0092.1021,1880.17%
2024/12/0900.00192.5092.50-11,184-0.08%
2024/12/06194.4000.0093.3011,1800.08%
2024/12/04194.8000.0094.6011,1640.09%
2024/12/020.195.0000.0094.400.11,1580.00%
2024/11/2900.000.197.8097.50-0.11,136-0.01%
2024/11/280.192.6000.0092.400.11,1100.00%
2024/11/261.193.80194.0094.000.11,0840.00%
2024/11/25195.0000.0093.8011,0790.09%
2024/11/220.195.6000.0093.800.11,0310.00%
2024/11/190.195.8000.0096.000.11,0150.00%
2024/11/1300.007107.00106.50-7946-0.74%
2024/11/061102.5000.00102.5018260.12%
2024/11/0500.003103.50106.00-3782-0.38%
2024/11/040101.4100.00100.0007580.00%
2024/10/3000.002.1101.56102.00-2.1617-0.34%
2024/10/281102.001102.00102.0005760.00%
2024/10/24299.10298.3098.3004940.00%
2024/10/2300.002.294.2893.70-2.2424-0.52%
2024/10/0900.000.190.3089.50-0.1508-0.02%
2024/10/080.192.15393.0091.10-2.9507-0.57%
2024/09/260.187.4000.0086.600.15760.01%
2024/09/0300.00086.4085.7007130.00%
2024/08/2200.000.287.0086.60-0.2740-0.03%
2024/08/190.184.6000.0084.500.17390.01%
2024/08/09385.4000.0085.4037830.38%
2024/08/06583.4000.0080.8057830.64%
2024/08/053.183.0700.0083.003.17640.40%
2024/07/31093.3000.0093.2007360.00%
2024/07/290.195.4000.0094.500.17360.01%
2024/07/2600.000.197.3097.60-0.1729-0.01%
2024/07/190.297.0300.0094.200.27080.02%
2024/07/170.198.0000.0098.200.16580.02%
2024/07/15298.25298.4098.4006630.00%
2024/07/12095.8000.0095.6006480.00%
2024/07/111.195.60696.0795.20-5650-0.76%
2024/07/10196.6000.0096.6016580.15%
2024/07/032.197.33197.7096.701.16280.17%
2024/07/022.198.8000.0097.802.16230.33%
2024/07/01098.014.3100.49101.00-4.2610-0.69%
2024/06/28097.2000.0097.5005810.00%
2024/06/27096.5000.0095.7005820.00%
2024/06/2600.00198.1097.60-1576-0.17%
2024/06/24193.9000.0093.2015890.17%
2024/06/21194.7000.0093.7016070.16%
2024/06/192.195.13193.8093.801.16370.17%
2024/06/183.195.7400.0095.403.16330.48%
2024/06/17395.64295.7595.5016440.16%
2024/06/141.295.23596.1095.30-3.9655-0.59%
2024/06/1300.001.597.0396.90-1.5651-0.22%
2024/06/11295.50295.0095.4006360.00%
2024/06/0700.00194.5094.50-1644-0.16%
2024/06/0600.00191.1091.10-1630-0.16%
2024/06/05193.20192.9092.9006320.00%
2024/06/0300.00190.9090.70-1693-0.14%
2024/05/302.190.9500.0090.302.17370.28%
2024/05/291.191.6300.0091.501.17470.14%
2024/05/271.192.0900.0091.701.17760.14%
2024/05/24592.8000.0092.8058080.62%
2024/05/1700.00599.0097.90-5872-0.57%
2024/05/1600.00196.0095.10-1869-0.11%
2024/05/1400.00196.0094.30-11,043-0.10%
2024/04/30194.00195.0093.7001,4250.00%
2024/04/190.190.6000.0089.000.11,5230.00%
2024/04/180.192.0000.0093.600.11,5250.00%
2024/04/160.192.5000.0091.000.11,5570.00%
2024/04/15594.80094.1094.1051,5650.32%
2024/04/12197.1000.0097.1011,5790.06%
2024/04/09197.8000.0097.6011,7220.06%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-30天前
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章
 
 
47小時3